Skip to main content
padlock icon - secure page this page is secure

Targeting Serine Proteases in Asthma

Buy Article:

$68.00 + tax (Refund Policy)

Leukocytes and lung structural cells contribute to the pathophysiology of asthma through the production of numerous mediators including serine proteases. Such proteases include mast cell tryptase and chymase; neutrophil elastase, cathepsin G and myeloblastin (proteinase 3); bronchial epithelial cell-derived transmembrane protease, serine 11D (human airway trypsin-like protease); cytotoxic T lymphocyte- and natural killer cell-derived granzyme B; and, eosinophil serine protease 1 (testisin). Considerable effort to develop potent and selective inhibitors, mostly non-peptidic, especially targeting tryptase and chymase have been made in the last few years. This review presents promising inhibitors, currently in the research and development pipeline. Some endogenous inhibitors and other compounds purified from nonhuman species are also discussed.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Serine protease inhibitors; asthma; chymase; inflammation; leukocyte elastase; tryptase

Document Type: Research Article

Affiliations: Hopital Laval, Room M2691, 2725 Chemin Sainte-Foy, Sainte-Foy (Quebec), Canada G1V 4G5.

Publication date: February 1, 2006

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more